Compare Heron Therapeutics Inc (HRTX) vs SoundHound AI Inc (SOUN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs SoundHound AI Inc — how do they compare? Heron Therapeutics Inc trades at $0.36 (market cap $68.01M), while SoundHound AI Inc trades at $5.6 (market cap $2.45B). The key difference: SoundHound AI Inc is far larger — about 36× Heron Therapeutics Inc's market cap, and SoundHound AI Inc is more actively traded (16,881,989 versus 1,891,941). Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and SoundHound AI Inc for 23 Days on average.
| HRTX | SOUN | |
|---|---|---|
Market Cap | $68.01M | $2.45B |
Volume | 1,891,941 | 16,881,989 |
Sector | Health | Technology |
52-Week High | $1.49 | $21.40 |
52-Week Low | $0.27 | $5.52 |
Typical Hold Time | 35 Days | 23 Days |
Enterprise Value | $174.75M | $2.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
SoundHound AI (SOUN) trades at $5.63, down 1.57% today, with a bearish technical signal despite recent earnings beats. The company shows strong revenue growth ($169M in 2025, projected $203M in 2026) but significant net losses (-$14M in 2025, -$137M projected in 2026). Recent developments include expansion into banking AI agents and the OASYS Edge embedded architecture launch for vehicles and smart devices (GlobeNewsWire, September 24, 2026).
Investment outlook balances high growth potential against substantial profitability challenges. Analyst consensus is bullish with a $9.33 price target (75% buy ratings), but negative cash flow from operations and insider selling pose near-term risks. The stock's success depends on converting revenue growth to profitability while managing integration risks from acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →
